This tip sheet provides guidance on the use of antipsychotic medication among long-stay nursing home residents. The resource focuses on measuring the percentage of residents receiving antipsychotic drugs within a seven-day look-back period or as shown on claims or encounter data within the target period. It details MDS coding requirements, exclusion criteria (such as residents with documented diagnoses of schizophrenia, Tourette’s syndrome, or Huntington's disease, residents not continuously enrolled in Medicare or Medicaid, and residents on hospice), and the seven-day assessment period guidelines.
